vs
Cellectis S.A.（CLLS）与FIRST US BANCSHARES, INC.（FUSB）财务数据对比。点击上方公司名可切换其他公司
FIRST US BANCSHARES, INC.的季度营收约是Cellectis S.A.的1.1倍（$10.4M vs $9.5M），FIRST US BANCSHARES, INC.净利率更高（20.4% vs -265.9%，领先286.3%），Cellectis S.A.同比增速更快（375.0% vs 7.1%），Cellectis S.A.自由现金流更多（$27.6M vs $9.1M）
Cellectis S.A.是一家法国生物制药公司，专注于开发用于癌症免疫治疗的基因编辑嵌合抗原受体T细胞技术，目前在巴黎、纽约以及北卡罗来纳州罗利均设有办公机构，在肿瘤免疫基因编辑疗法领域拥有多年研发积累。
第一美国银行控股公司是一家银行控股企业，核心子公司第一公民银行在美国23个州经营着超过500家网点，另一家子公司硅谷银行则在15个州设有39个办事处，是美国规模较大的银行机构之一，总部位于北卡罗来纳州罗利。
CLLS vs FUSB — 直观对比
营收规模更大
FUSB
是对方的1.1倍
$9.5M
营收增速更快
CLLS
高出367.9%
7.1%
净利率更高
FUSB
高出286.3%
-265.9%
自由现金流更多
CLLS
多$18.5M
$9.1M
损益表 — Q2 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.5M | $10.4M |
| 净利润 | $-25.3M | $2.1M |
| 毛利率 | — | — |
| 营业利润率 | -181.1% | 28.1% |
| 净利率 | -265.9% | 20.4% |
| 营收同比 | 375.0% | 7.1% |
| 净利润同比 | -51.9% | 24.2% |
| 每股收益（稀释后） | $-0.28 | $0.36 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLLSFUSB
| Q4 25 | — | $10.4M | ||
| Q3 25 | — | $10.5M | ||
| Q2 25 | — | $10.3M | ||
| Q1 25 | — | $9.8M | ||
| Q4 24 | — | $9.7M | ||
| Q3 24 | — | $10.1M | ||
| Q2 24 | $9.5M | $10.0M | ||
| Q1 24 | — | $9.9M |
净利润CLLSFUSB
| Q4 25 | — | $2.1M | ||
| Q3 25 | — | $1.9M | ||
| Q2 25 | — | $155.0K | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | — | $1.7M | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | $-25.3M | $2.1M | ||
| Q1 24 | — | $2.1M |
营业利润率CLLSFUSB
| Q4 25 | — | 28.1% | ||
| Q3 25 | — | 23.9% | ||
| Q2 25 | — | 1.6% | ||
| Q1 25 | — | 23.8% | ||
| Q4 24 | — | 23.8% | ||
| Q3 24 | — | 29.2% | ||
| Q2 24 | -181.1% | 27.4% | ||
| Q1 24 | — | 27.8% |
净利率CLLSFUSB
| Q4 25 | — | 20.4% | ||
| Q3 25 | — | 18.4% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 18.1% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | -265.9% | 21.2% | ||
| Q1 24 | — | 21.3% |
每股收益（稀释后）CLLSFUSB
| Q4 25 | — | $0.36 | ||
| Q3 25 | — | $0.32 | ||
| Q2 25 | — | $0.03 | ||
| Q1 25 | — | $0.29 | ||
| Q4 24 | — | $0.29 | ||
| Q3 24 | — | $0.36 | ||
| Q2 24 | $-0.28 | $0.34 | ||
| Q1 24 | — | $0.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $149.0M | $73.5M |
| 总债务越低越好 | — | $10.9M |
| 股东权益账面价值 | $148.6M | $105.6M |
| 总资产 | $407.1M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.10× |
8季度趋势，按日历期对齐
现金及短期投资CLLSFUSB
| Q4 25 | — | $73.5M | ||
| Q3 25 | — | $54.7M | ||
| Q2 25 | — | $54.0M | ||
| Q1 25 | — | $56.0M | ||
| Q4 24 | — | $47.2M | ||
| Q3 24 | — | $82.3M | ||
| Q2 24 | $149.0M | $58.2M | ||
| Q1 24 | — | $60.2M |
总债务CLLSFUSB
| Q4 25 | — | $10.9M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $10.9M | ||
| Q1 25 | — | $10.9M | ||
| Q4 24 | — | $10.9M | ||
| Q3 24 | — | $10.9M | ||
| Q2 24 | — | $10.8M | ||
| Q1 24 | — | $10.8M |
股东权益CLLSFUSB
| Q4 25 | — | $105.6M | ||
| Q3 25 | — | $104.2M | ||
| Q2 25 | — | $101.9M | ||
| Q1 25 | — | $101.2M | ||
| Q4 24 | — | $98.6M | ||
| Q3 24 | — | $98.5M | ||
| Q2 24 | $148.6M | $93.8M | ||
| Q1 24 | — | $92.3M |
总资产CLLSFUSB
| Q4 25 | — | $1.2B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | $407.1M | $1.1B | ||
| Q1 24 | — | $1.1B |
负债/权益比CLLSFUSB
| Q4 25 | — | 0.10× | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.11× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.9M | $12.3M |
| 自由现金流经营现金流 - 资本支出 | $27.6M | $9.1M |
| 自由现金流率自由现金流/营收 | 290.5% | 87.2% |
| 资本支出强度资本支出/营收 | 13.2% | 31.1% |
| 现金转化率经营现金流/净利润 | — | 5.79× |
| 过去12个月自由现金流最近4个季度 | — | $16.0M |
8季度趋势，按日历期对齐
经营现金流CLLSFUSB
| Q4 25 | — | $12.3M | ||
| Q3 25 | — | $4.2M | ||
| Q2 25 | — | $3.9M | ||
| Q1 25 | — | $1.8M | ||
| Q4 24 | — | $7.8M | ||
| Q3 24 | — | $1.9M | ||
| Q2 24 | $28.9M | $2.5M | ||
| Q1 24 | — | $825.0K |
自由现金流CLLSFUSB
| Q4 25 | — | $9.1M | ||
| Q3 25 | — | $3.6M | ||
| Q2 25 | — | $1.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $5.7M | ||
| Q3 24 | — | $1.3M | ||
| Q2 24 | $27.6M | $2.3M | ||
| Q1 24 | — | $-142.0K |
自由现金流率CLLSFUSB
| Q4 25 | — | 87.2% | ||
| Q3 25 | — | 34.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 17.2% | ||
| Q4 24 | — | 58.2% | ||
| Q3 24 | — | 12.7% | ||
| Q2 24 | 290.5% | 23.5% | ||
| Q1 24 | — | -1.4% |
资本支出强度CLLSFUSB
| Q4 25 | — | 31.1% | ||
| Q3 25 | — | 5.9% | ||
| Q2 25 | — | 21.8% | ||
| Q1 25 | — | 0.7% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 6.6% | ||
| Q2 24 | 13.2% | 2.0% | ||
| Q1 24 | — | 9.8% |
现金转化率CLLSFUSB
| Q4 25 | — | 5.79× | ||
| Q3 25 | — | 2.18× | ||
| Q2 25 | — | 25.16× | ||
| Q1 25 | — | 0.99× | ||
| Q4 24 | — | 4.53× | ||
| Q3 24 | — | 0.87× | ||
| Q2 24 | — | 1.20× | ||
| Q1 24 | — | 0.39× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
